IPO registrations (S-1, F-1) · Registrants
Imunon, Inc.
- SEC CIK
- 749647 · filings on EDGAR ↗
- Former names
- CELSION CORP (2007–2022); Celsion CORP (2007–2022); CHEUNG LABORATORIES INC (1996–1998)
- Registration
- Form S-1, first filed 2000-12-14, last 2026-10-28; 16 initial registrations, 23 amendments
- Outcome
- Final prospectus filed 2017-02-16; declared effective 2009-04-17; withdrawal requested 2000-12-29
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 997 LENOX DRIVE, SUITE 100, Lawrenceville, NJ 08648
- EIN
- 52-1256615
- Ticker
- IMNN (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Imunon, Inc. on the corporate pages
On this site
- Form 5500 plan sponsor: IMUNON, INC. EXACT (EIN (EXACT))
- Form D issuer: Imunon, Inc. EXACT (CIK (EXACT))
- SEC filer: Celsion CORP EXACT (CIK (EXACT))
Filings 69
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-12-14 | S-1 | S-1 (registration) | CELSION CORP | 0000950133-00-004879 ↗ |
| 2000-12-29 | RW | RW (withdrawal request) | CELSION CORP | 0000950133-00-005028 ↗ |
| 2009-04-17 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-09-001001 ↗ |
| 2010-07-26 | S-1 | S-1 (registration) | Celsion CORP | 0001047469-10-006614 ↗ |
| 2010-08-05 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001047469-10-007070 ↗ |
| 2010-08-09 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-10-002403 ↗ |
| 2011-04-08 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-11-000931 ↗ |
| 2011-06-24 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-11-001960 ↗ |
| 2011-08-24 | S-1 | S-1 (registration) | Celsion CORP | 0000749647-11-000118 ↗ |
| 2011-09-14 | S-1/A | S-1/A (amendment) | Celsion CORP | 0000749647-11-000125 ↗ |
| 2011-09-22 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-11-002786 ↗ |
| 2011-12-21 | S-1 | S-1 (registration) | Celsion CORP | 0000749647-11-000165 ↗ |
| 2012-02-03 | S-1/A | S-1/A (amendment) | Celsion CORP | 0000749647-12-000004 ↗ |
| 2012-02-08 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-12-000427 ↗ |
| 2012-09-14 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-12-002748 ↗ |
| 2014-09-30 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-14-002905 ↗ |
| 2014-09-30 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-14-002914 ↗ |
| 2015-07-30 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-15-002117 ↗ |
| 2015-09-25 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-15-002590 ↗ |
| 2016-10-28 | RW | RW (withdrawal request) | Celsion CORP | 0001437749-16-040542 ↗ |
| 2016-10-31 | S-1 | S-1 (registration) | Celsion CORP | 0001437749-16-040660 ↗ |
| 2016-11-16 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-16-042271 ↗ |
| 2016-11-16 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-16-006250 ↗ |
| 2016-12-23 | S-1 | S-1 (registration) | Celsion CORP | 0001437749-16-043761 ↗ |
| 2017-01-23 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-000937 ↗ |
| 2017-02-13 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-002161 ↗ |
| 2017-02-13 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-002221 ↗ |
| 2017-02-14 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-002331 ↗ |
| 2017-02-14 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-17-000382 ↗ |
| 2017-02-16 | 424B4 | 424B4 (final prospectus) | Celsion CORP | 0001437749-17-002620 ↗ |
| 2017-04-05 | S-1 | S-1 (registration) | Celsion CORP | 0001437749-17-006146 ↗ |
| 2017-04-18 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-006730 ↗ |
| 2017-04-19 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-17-000880 ↗ |
| 2017-04-25 | S-1 | S-1 (registration) | Celsion CORP | 0001437749-17-007157 ↗ |
| 2017-05-30 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-010235 ↗ |
| 2017-06-02 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-010561 ↗ |
| 2017-06-06 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-010723 ↗ |
| 2017-06-15 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-011299 ↗ |
| 2017-06-16 | RW | RW (withdrawal request) | Celsion CORP | 0001437749-17-011368 ↗ |
| 2017-07-21 | S-1 | S-1 (registration) | Celsion CORP | 0001437749-17-012940 ↗ |
| 2017-08-02 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-013591 ↗ |
| 2017-08-04 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-17-002045 ↗ |
| 2017-11-14 | S-1 | S-1 (registration) | Celsion CORP | 0001437749-17-019176 ↗ |
| 2017-11-22 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-019770 ↗ |
| 2017-12-01 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001437749-17-020067 ↗ |
| 2017-12-08 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-17-003187 ↗ |
| 2018-10-12 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-18-002609 ↗ |
| 2019-11-08 | S-1 | S-1 (registration) | Celsion CORP | 0001493152-19-016715 ↗ |
| 2019-11-22 | S-1/A | S-1/A (amendment) | Celsion CORP | 0001493152-19-018258 ↗ |
| 2019-11-27 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-19-002686 ↗ |
| 2020-08-13 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-20-002138 ↗ |
| 2020-10-27 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-20-003002 ↗ |
| 2021-03-30 | EFFECT | EFFECT (declared effective) | Celsion CORP | 9999999995-21-001213 ↗ |
| 2023-12-20 | S-1 | S-1 (registration) | Imunon, Inc. | 0001493152-23-045609 ↗ |
| 2024-01-18 | S-1/A | S-1/A (amendment) | Imunon, Inc. | 0001493152-24-002801 ↗ |
| 2024-02-09 | S-1/A | S-1/A (amendment) | Imunon, Inc. | 0001493152-24-005668 ↗ |
| 2024-04-10 | RW | RW (withdrawal request) | Imunon, Inc. | 0001493152-24-014207 ↗ |
| 2024-05-22 | EFFECT | EFFECT (declared effective) | Imunon, Inc. | 9999999995-24-001628 ↗ |
| 2024-08-29 | S-1 | S-1 (registration) | Imunon, Inc. | 0001493152-24-034312 ↗ |
| 2024-09-20 | S-1/A | S-1/A (amendment) | Imunon, Inc. | 0001493152-24-037591 ↗ |
| 2024-09-26 | EFFECT | EFFECT (declared effective) | Imunon, Inc. | 9999999995-24-002975 ↗ |
| 2025-04-04 | S-1 | S-1 (registration) | Imunon, Inc. | 0001641172-25-002783 ↗ |
| 2025-05-13 | S-1/A | S-1/A (amendment) | Imunon, Inc. | 0001641172-25-009814 ↗ |
| 2025-05-19 | S-1/A | S-1/A (amendment) | Imunon, Inc. | 0001641172-25-011388 ↗ |
| 2025-05-22 | RW | RW (withdrawal request) | Imunon, Inc. | 0001641172-25-011997 ↗ |
| 2025-05-30 | S-1 | S-1 (registration) | Imunon, Inc. | 0001641172-25-013088 ↗ |
| 2025-06-13 | EFFECT | EFFECT (declared effective) | Imunon, Inc. | 9999999995-25-001928 ↗ |
| 2026-10-27 | S-1 | S-1 (registration) | Imunon, Inc. | 0001493152-26-048630 ↗ |
| 2026-10-28 | S-1/A | S-1/A (amendment) | Imunon, Inc. | 0001493152-26-048776 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Hahne William | Director; Officer | VP - Clin. Dev. & Med. Affairs; VP of Clinical Development; VP of Research & Development | 9 | 2006–2007 | |
| DEASEY ANTHONY P | Officer | EVP, CFO; EVP-COO, CFO | 3 | 2006–2007 | |
| Finkle Carolyn | Officer | VP - Regulatory Affairs | 1 | 2006 | |
| LINK MAX | Director | 27 | 2006–2014 | ||
| OLANOFF LAWRENCE S | Officer | President & CEO | 1 | 2006 | |
| Oleck Michael | Officer | VP - Operations | 2 | 2006–2007 | |
| PACE GARY W | Director | 8 | 2006–2010 | ||
| TIHON CLAUDE | Director | 1 | 2006 | ||
| VENKAT KRIS | Director | 3 | 2006–2007 | ||
| WEAVER GREGORY L | Director; Officer | CFO; Chief Financial Officer; SVP & Chief Financial Officer | 15 | 2006–2013 | |
| Tardugno Michael H | Director,Officer; Officer | CEO; Chairman, President and CEO; Chief Executive Officer; Chief Executive Offier; Executive Chairman of Board; President and CEO; President & CEO; President, CEO | 85 | 2007–2026 | |
| Chow Pok Yu Augustine | Director | 27 | 2007–2023 | ||
| Susie Paul B. | Officer | Chief Accounting Officer | 3 | 2007–2008 | |
| Borys Nicholas | Officer | Chief Medical Officer; CMO; VP & Chief Medical Officer | 22 | 2008–2019 | |
| Moran Sean F. | Officer | CFO; Chief Financial Officer | 5 | 2008–2009 | |
| Tumminello Timothy J | Officer; Other | CAO; Controller; Controller and CAO; Controller & CAO; Interim CAO, Controller; Interim Chief Accnt Officer; Interim Chief Accounting Off. | 25 | 2010–2022 | |
| CHURCH JEFFREY WAYNE | Officer | CFO; Chief Financial Officer; Senior Vice President; SVP Corp Bus Strategy/IR; SVP Investor Relations; SVP - IR/PR | 28 | 2010–2026 | |
| Hooper Robert W | Director | 35 | 2010–2022 | ||
| Martinez Alberto R | Director | 48 | 2010–2020 | ||
| Fritz Frederick J. | Director | 52 | 2011–2026 | ||
| Anwer Khursheed | Officer | Chief Scientific Officer | 13 | 2014–2026 | |
| EGWU, Inc. fka EGEN, Inc. | TenPercentOwner | 9 | 2014–2015 | ||
| Braun Donald P | Director | 24 | 2015–2026 | ||
| Voss Andreas | Director | 11 | 2015–2021 | ||
| Lindborg Stacy | Director; Director,Officer | President and CEO | 26 | 2021–2026 | |
| Pellizzari Christine A | Director | 13 | 2021–2026 | ||
| Kardaras Constantine John | Officer | Chief Accounting Officer | 4 | 2021–2022 | |
| Le Goff Corinne | Director,Officer | President and CEO | 3 | 2022–2023 | |
| Dentzer James E | Director | 11 | 2022–2026 | ||
| Hazard Sebastien | Officer | Chief Medical Officer | 2 | 2023 | |
| Gaiero David G | Officer | Chief Financial Officer | 1 | 2024 | |
| Eylward Susan | Officer | General Counsel and Corp Sec | 11 | 2024–2026 | |
| Faller Douglas Vincent | Officer | Chief Medical Officer | 11 | 2025–2026 | |
| Bragg Kimberly | Officer | CFO | 3 | 2025–2026 | |
| Blacher Joshua | Officer | CFO | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-05-28 | Imunon, Inc. | Biotechnology | $3,250,001 | $3,250,001 | 3 | 1 |
| 2024-08-16 | Imunon, Inc. | Biotechnology | $10,000,000 | $10,000,000 | 4 | 1 |
| 2015-06-08 | Celsion CORP | Pharmaceuticals | $5,070,000 | $5,070,000 | 3 | 1 |
| 2014-06-24 | Celsion CORP | Pharmaceuticals | $8,500,000 | $8,500,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.